Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

JacksinPA said:

https://www.reuters.com/article/us-...rly-1000-workers-to-be-affected-idUSKCN1LS2EY

(Reuters) - Japan’s Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the closing of its Shire Plc acquisition.

The Deerfield site employs just under 1,000 people — about a fifth of its U.S. employees — and a number of them will be provided with job offers and/or relocation opportunities, a Takeda spokeswoman told Reuters on Wednesday.

The company did not provide specifics on what percentage of the affected employees may face job cuts.
============================================================================
'In May, Takeda agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion), a deal that will make the firm closer to becoming a top 10 global drugmaker.'

This looks like a standard corporate consolidation or rationalization following a mega merger. Too few desks, too my duplicate people.

Takeda has a growing number of blockbuster drugs, including

Vedolizumab (brand name: Entyvio) is a treatment for moderate to severe ulcerative colitis or moderate to severe Crohn's disease.

Click to expand...

Felis Leo said:

Well, that is unfortunate for those workers of Illinois and great for the future employees living in and around Boston. But I do not see how this is some wicked or immoral thing that needs to be "rationalized" (if that is what you were implying). As you say, if they do not need that many worker to fill the jobs required, why on Earth should they continue employing them?

Click to expand...

JacksinPA said:

'Rationalization' is one of the standard terms used in corporate life to signal layoffs due to joint consolidation.

Click to expand...

Felis Leo said:

Ah, gotcha.

What are your thoughts regarding the merger?

Click to expand...

JacksinPA said:

I worked in big pharma for many years & saw nothing but consolidation by way of mergers. Not good for a lot of people including me.

Click to expand...

JacksinPA said:

https://www.reuters.com/article/us-...rly-1000-workers-to-be-affected-idUSKCN1LS2EY

(Reuters) - Japan’s Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the closing of its Shire Plc acquisition.

The Deerfield site employs just under 1,000 people — about a fifth of its U.S. employees — and a number of them will be provided with job offers and/or relocation opportunities, a Takeda spokeswoman told Reuters on Wednesday.

The company did not provide specifics on what percentage of the affected employees may face job cuts.
============================================================================
'In May, Takeda agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion), a deal that will make the firm closer to becoming a top 10 global drugmaker.'

This looks like a standard corporate consolidation or rationalization following a mega merger. Too few desks, too my duplicate people.

Takeda has a growing number of blockbuster drugs, including

Vedolizumab (brand name: Entyvio) is a treatment for moderate to severe ulcerative colitis or moderate to severe Crohn's disease.

Click to expand...

Felis Leo said:

I can only imagine. I cannot claim to know much about the current state of the pharmaceutical industry, and the more I hear the more depressed I feel about it.

Click to expand...

Mycroft said:

Sucks for some people...great for other people...but, of course, such a decision ultimately depends on whether it's good for the company.

Click to expand...

JacksinPA said:

https://www.reuters.com/article/us-...rly-1000-workers-to-be-affected-idUSKCN1LS2EY

(Reuters) - Japan’s Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the closing of its Shire Plc acquisition.

The Deerfield site employs just under 1,000 people — about a fifth of its U.S. employees — and a number of them will be provided with job offers and/or relocation opportunities, a Takeda spokeswoman told Reuters on Wednesday.

The company did not provide specifics on what percentage of the affected employees may face job cuts.
============================================================================
'In May, Takeda agreed to buy London-listed Shire for 45.3 billion pounds ($62 billion), a deal that will make the firm closer to becoming a top 10 global drugmaker.'

This looks like a standard corporate consolidation or rationalization following a mega merger. Too few desks, too my duplicate people.

Takeda has a growing number of blockbuster drugs, including

Vedolizumab (brand name: Entyvio) is a treatment for moderate to severe ulcerative colitis or moderate to severe Crohn's disease.

Click to expand...

JacksinPA said:

My negative feeling about big pharma is that they are putting most of their R&D resources behind developing expensive drugs that select patents have to take every day just to stay alive, like for metastatic breast cancer. Pfizer dropped their big anti-Alzheimer;'s R&D program. Few companies are spending any effort on new antibiotics. It's a big shift from pure medicine to pure profit.

Click to expand...